Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. [electronic resource] by
- Lu, Jing
- Qian, Yimin
- Altieri, Martha
- Dong, Hanqing
- Wang, Jing
- Raina, Kanak
- Hines, John
- Winkler, James D
- Crew, Andrew P
- Coleman, Kevin
- Crews, Craig M
Producer: 20160405
In:
Chemistry & biology vol. 22
Availability: No items available.
|
|
6.
|
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance. [electronic resource] by
- Salami, Jemilat
- Alabi, Shanique
- Willard, Ryan R
- Vitale, Nick J
- Wang, Jing
- Dong, Hanqing
- Jin, Meizhong
- McDonnell, Donald P
- Crew, Andrew P
- Neklesa, Taavi K
- Crews, Craig M
Publication details: Communications biology 2018
In:
Communications biology vol. 1
Availability: No items available.
|
|
7.
|
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. [electronic resource] by
- Raina, Kanak
- Lu, Jing
- Qian, Yimin
- Altieri, Martha
- Gordon, Deborah
- Rossi, Ann Marie K
- Wang, Jing
- Chen, Xin
- Dong, Hanqing
- Siu, Kam
- Winkler, James D
- Crew, Andrew P
- Crews, Craig M
- Coleman, Kevin G
Producer: 20170814
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 113
Availability: No items available.
|
|
8.
|
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. [electronic resource] by
- Burslem, George M
- Smith, Blake E
- Lai, Ashton C
- Jaime-Figueroa, Saul
- McQuaid, Daniel C
- Bondeson, Daniel P
- Toure, Momar
- Dong, Hanqing
- Qian, Yimin
- Wang, Jing
- Crew, Andrew P
- Hines, John
- Crews, Craig M
Producer: 20181226
In:
Cell chemical biology vol. 25
Availability: No items available.
|
|
9.
|
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1. [electronic resource] by
- Crew, Andrew P
- Raina, Kanak
- Dong, Hanqing
- Qian, Yimin
- Wang, Jing
- Vigil, Dominico
- Serebrenik, Yevgeniy V
- Hamman, Brian D
- Morgan, Alicia
- Ferraro, Caterina
- Siu, Kam
- Neklesa, Taavi K
- Winkler, James D
- Coleman, Kevin G
- Crews, Craig M
Producer: 20190222
In:
Journal of medicinal chemistry vol. 61
Availability: No items available.
|
|
10.
|
Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin. [electronic resource] by
- Bhagwat, Shripad V
- Gokhale, Prafulla C
- Crew, Andrew P
- Cooke, Andy
- Yao, Yan
- Mantis, Christine
- Kahler, Jennifer
- Workman, Jennifer
- Bittner, Mark
- Dudkin, Lorina
- Epstein, David M
- Gibson, Neil W
- Wild, Robert
- Arnold, Lee D
- Houghton, Peter J
- Pachter, Jonathan A
Producer: 20111219
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
11.
|
Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitors. [electronic resource] by
- Jin, Meizhong
- Wang, Jing
- Kleinberg, Andrew
- Kadalbajoo, Mridula
- Siu, Kam W
- Cooke, Andrew
- Bittner, Mark A
- Yao, Yan
- Thelemann, April
- Ji, Qunsheng
- Bhagwat, Shripad
- Mulvihill, Kristen M
- Rechka, Josef A
- Pachter, Jonathan A
- Crew, Andrew P
- Epstein, David
- Mulvihill, Mark J
Producer: 20131031
In:
Bioorganic & medicinal chemistry letters vol. 23
Availability: No items available.
|
|
12.
|
Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics. [electronic resource] by
- Hornberger, Keith R
- Chen, Xin
- Crew, Andrew P
- Kleinberg, Andrew
- Ma, Lifu
- Mulvihill, Mark J
- Wang, Jing
- Wilde, Victoria L
- Albertella, Mark
- Bittner, Mark
- Cooke, Andrew
- Kadhim, Salam
- Kahler, Jennifer
- Maresca, Paul
- May, Earl
- Meyn, Peter
- Romashko, Darlene
- Tokar, Brianna
- Turton, Roy
Producer: 20140130
In:
Bioorganic & medicinal chemistry letters vol. 23
Availability: No items available.
|
|
13.
|
A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes. [electronic resource] by
- Li, An-Hu
- Ahmed, Eilaf
- Chen, Xin
- Cox, Matthew
- Crew, Andrew P
- Dong, Han-Qing
- Jin, Meizhong
- Ma, Lifu
- Panicker, Bijoy
- Siu, Kam W
- Steinig, Arno G
- Stolz, Kathryn M
- Tavares, Paula A R
- Volk, Brian
- Weng, Qinghua
- Werner, Doug
- Mulvihill, Mark J
Producer: 20070313
In:
Organic & biomolecular chemistry vol. 5
Availability: No items available.
|
|
14.
|
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors. [electronic resource] by
- Mulvihill, Mark J
- Ji, Qun-Sheng
- Werner, Doug
- Beck, Patricia
- Cesario, Cara
- Cooke, Andrew
- Cox, Matthew
- Crew, Andrew
- Dong, Hanqing
- Feng, Lixin
- Foreman, K W
- Mak, Gilda
- Nigro, Anthony
- O'Connor, Matthew
- Saroglou, Lydia
- Stolz, Kathryn M
- Sujka, Izabela
- Volk, Brian
- Weng, Qinghua
- Wilkes, Robin
Producer: 20070413
In:
Bioorganic & medicinal chemistry letters vol. 17
Availability: No items available.
|
|
15.
|
Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2. [electronic resource] by
- Crew, Andrew P
- Bhagwat, Shripad V
- Dong, Hanqing
- Bittner, Mark A
- Chan, Anna
- Chen, Xin
- Coate, Heather
- Cooke, Andrew
- Gokhale, Prafulla C
- Honda, Ayako
- Jin, Meizhong
- Kahler, Jennifer
- Mantis, Christine
- Mulvihill, Mark J
- Tavares-Greco, Paula A
- Volk, Brian
- Wang, Jing
- Werner, Douglas S
- Arnold, Lee D
- Pachter, Jonathan A
- Wild, Robert
- Gibson, Neil W
Producer: 20110711
In:
Bioorganic & medicinal chemistry letters vol. 21
Availability: No items available.
|
|
16.
|
Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1. [electronic resource] by
- Hornberger, Keith R
- Berger, Dan M
- Crew, Andrew P
- Dong, Hanqing
- Kleinberg, Andrew
- Li, An-Hu
- Medeiros, Matthew R
- Mulvihill, Mark J
- Siu, Kam
- Tarrant, James
- Wang, Jing
- Weng, Felix
- Wilde, Victoria L
- Albertella, Mark
- Bittner, Mark
- Cooke, Andrew
- Gray, Michael J
- Maresca, Paul
- May, Earl
- Meyn, Peter
- Peick, William
- Romashko, Darlene
- Tanowitz, Michael
- Tokar, Brianna
Producer: 20140130
In:
Bioorganic & medicinal chemistry letters vol. 23
Availability: No items available.
|
|
17.
|
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models. [electronic resource] by
- Garton, Andrew J
- Crew, Andrew P A
- Franklin, Maryland
- Cooke, Andrew R
- Wynne, Graham M
- Castaldo, Linda
- Kahler, Jennifer
- Winski, Shannon L
- Franks, April
- Brown, Eric N
- Bittner, Mark A
- Keily, John F
- Briner, Paul
- Hidden, Chris
- Srebernak, Mary C
- Pirrit, Carrie
- O'Connor, Matthew
- Chan, Anna
- Vulevic, Bojana
- Henninger, Dwight
- Hart, Karen
- Sennello, Regina
- Li, An-Hu
- Zhang, Tao
- Richardson, Frank
- Emerson, David L
- Castelhano, Arlindo L
- Arnold, Lee D
- Gibson, Neil W
Producer: 20060214
In:
Cancer research vol. 66
Availability: No items available.
|